Galderma have announced that the Restylane Fynesse dermal filler from the Optimal Balance Technology (OBT) range will be discontinued as of June 2021. Primarily indicated for the correction of superficial fine lines, Fynesse will be replaced within the portfolio by Restylane Refyne, which is a more versatile product, with a low lifting capacity but still with a soft gel formulation. Restylane Refyne is indicated for treating moderate wrinkles and can address more prominent areas of concern, such as the nasolabial folds and marionette lines. The Restylane OBT (Optimal Balance Technology™) range is designed for contouring and expression, and will now include four key products: Refyne, Kysse, Defyne and Volyme.
Leaflet Restylane Fynesse EU 2020 Restylane Refyne EU IFU 2020